Quick Sequential Organ Failure Assessment Score and the Modified Early Warning Score for Predicting Clinical Deterioration in General Ward Patients Regardless of Suspected Infection

Background@#The quick sequential organ failure assessment (qSOFA) score is suggested to use for screening patients with a high risk of clinical deterioration in the general wards, which could simply be regarded as a general early warning score. However, comparison of unselected admissions to highlight the benefits of introducing qSOFA in hospitals already using Modified Early Warning Score (MEWS) remains unclear. We sought to compare qSOFA with MEWS for predicting clinical deterioration in general ward patients regardless of suspected infection. @*Methods@#The predictive performance of qSOFA and MEWS for in-hospital cardiac arrest (IHCA) or unexpected intensive care unit (ICU) transfer was compared with the areas under the receiver operating characteristic curve (AUC) analysis using the databases of vital signs collected from consecutive hospitalized adult patients over 12 months in five participating hospitals in Korea. @*Results@#Of 173,057 hospitalized patients included for analysis, 668 (0.39%) experienced the composite outcome. The discrimination for the composite outcome for MEWS (AUC, 0.777;95% confidence interval [CI], 0.770–0.781) was higher than that for qSOFA (AUC, 0.684;95% CI, 0.676–0.686; P < 0.001). In addition, MEWS was better for prediction of IHCA (AUC, 0.792; 95% CI, 0.781–0.795 vs. AUC, 0.640; 95% CI, 0.625–0.645; P < 0.001) and unexpected ICU transfer (AUC, 0.767; 95% CI, 0.760–0.773 vs. AUC, 0.716; 95% CI, 0.707–0.718; P < 0.001) than qSOFA. Using the MEWS at a cutoff of ≥ 5 would correctly reclassify 3.7% of patients from qSOFA score ≥ 2. Most patients met MEWS ≥ 5 criteria 13 hours before the composite outcome compared with 11 hours for qSOFA score ≥ 2. @*Conclusion@#MEWS is more accurate that qSOFA score for predicting IHCA or unexpected ICU transfer in patients outside the ICU. Our study suggests that qSOFA should not replace MEWS for identifying patients in the general wards at risk of poor outcome.

Carbon Dioxide Angiography: Scientific Principles and Practice

Carbon dioxide (CO2) is a colorless, odorless gas which occurs naturally in the atmosphere and human body. With the advent of digital subtraction angiography, the gas has been used as a safe and useful alternative contrast agent in both arteriography and venography. Because of its lack of renal toxicity and allergic potential, CO2 is a preferred contrast agent in patients with renal failure or contrast allergy, and particularly in patients who require large volumes of contrast medium for complex endovascular procedures. Understanding of the unique physical properties of CO2 (high solubility, low viscosity, buoyancy, and compressibility) is essential in obtaining a successful CO2 angiogram and in guiding endovascular intervention. Unlike iodinated contrast material, CO2 displaces the blood and produces a negative contrast for digital subtraction imaging. Indications for use of CO2 as a contrast agent include: aortography and runoff, detection of bleeding, renal transplant arteriography, portal vein visualization with wedged hepatic venous injection, venography, arterial and venous interventions, and endovascular aneurysm repair. CO2 should not be used in the thoracic aorta, the coronary artery, and cerebral circulation. Exploitation of CO2 properties, avoidance of air contamination and facile catheterization technique are important to the safe and effective performance of CO2 angiography and CO2-guided endovascular intervention.

Percutaneous Transhepatic Cholangiography and Biliary Drainage by Antegrade Puncture Technique: Technical Note

The antegrade puncture technique represents a new approach to percutaneous transhepatic cholangiography andbiliary drainage. With this technique, ductal puncture begins with the liver capsule toward the hepaticparenchyma. This report briefly describes this new technique, and its safety and feasibility.

Carbon Dioxide as a Venous Contrast Agent: Applications in Interventional Radiology

PURPOSE: To evaluate the safety and usefulness of carbon dioxide (CO2) as a venous contrast agent for upper-arm placement of peripherally inserted central venous catheter (PICC), vena caval filter placement, and for visualization of the portal vein in transjugular intrahepatic portosystemic shunt (TIPS). MATERIALS AND METHODS: About 20-30ml of CO2 was used as an alternative to iodinated contrast material for digital subtraction angiography (DSA) and fluoroscopy to guide upper-arm placement of PICC in 46 patients, for inferior venacavogram before filter placement in five, and for visualization of the portal vein during TIPS in two. Vital signs, peripheral arterial oxygen saturation, and renal function were checked during and after delivery of CO2. RESULTS: All CO2 DSA for PICC placement clearly delineated patency or stenosis of the central veins. In 41 of 46 patients (89%), PICC placement with CO2 guidance was successful. The mean number of venipunctures for PICC placement was 1.9, and the mean volume of CO2 injected for venipuncture was 35 ml. In five patients, Titanium Greenfield filters were successfully implanted into the inferior vena cava following CO2 vena cavography. In two patients in whom hepatopetal portal flow was seen on indirect portography, the portal vein was visualized by CO2-wedged hepatic venography. Injection of CO2 into the splenic vein following TIPS placement revealed shunt patency. Vital signs and oxygen saturation did not change, and there was no evidence of renal toxicity following CO2 injection. CONCLUSION: CO2 is a safe and useful alternative contrast agent for upper-arm placement of PICC, pre-filter placement cavography, and wedged hepatic venography and portography for TIPS.